Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Obesity/BMI-qualified patients are estimated to lead Patient Segment with 57.4% share in 2026
We know that without a better cost management structure, most employers are unable to cover these life-changing medications for their population, despite their extraordinary efficacy in reducing obesity, said Cody Fair, Chief Commercial Officer at Noom
It is currently advancing through Phase 3 clinical trials for obesity treatment
Severe or non-stop vomiting, or you can't keep fluids down (dehydration) Severe stomach pain, especially if it spreads to your back (possible pancreatitis) Upper-right belly pain, fever, or yellowing skin/eyes (gallbladder) Signs of an allergic reaction swelling, trouble breathing, a spreading rash These are class-wide GLP-1 warnings
Request a medication review to identify any drugs that might be interfering with GLP-1 effectiveness
Conversely, transplanting the microbiome from a healthy twin drives weight loss
